Analyst Ratings for ISIS Pharmaceuticals (ISIS) [Neutrals]

ISIS Rating Summary

ISIS Price Target Summary

* Over Last 12-Mos
  |   Expand Research on ISIS
Overall Rating: NEUTRAL   Rating Trend: Up   Avg. $ Target: $55.50 (+5.2%) * Over Last 12-Mos
Date Firm Type Rating
(Past)
PT
(Past)
Start $ End $ % Chg. Details
9/26/2014 Leerink Swann New Coverage Market Perform
(N/A)
40.00
(N/A)
40.30 52.75 30.89% Details
10/4/2013 JPMorgan New Coverage Neutral
(N/A)
37.00
(N/A)
35.83 52.75 47.22% Details
Like ISIS Ratings? Also take a look at SNY, SAN, BIIB, GSK

ISIS Ratings News